TM4SF1-Directed Antibody–Drug Conjugates Selectively Destroy Newly Formed Blood Vessels Induced by VEGF-A
Chi-Iou Lin, Yu Liu, Tracey E. Sciuto, Anne Merley, Harold F. Dvorak, Shou-Ching S. Jaminet · 2026
Read TM4SF1-Directed Antibody–Drug Conjugates Selectively Destroy Newly Formed Blood Vessels Induced by VEGF-A by Chi-Iou Lin, Yu Liu, Tracey E. Sciuto, Anne Merley, Harold F. Dvorak, Shou-Ching S. Jaminet (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13207009.txt.
Description
Lin and five co-authors test antibody-drug conjugates that target a protein on new blood vessels in mouse tumors, in a study from twenty twenty-six. The protein sits on both tumor vessels and tumor cells and is taken inside the cell. Prior work showed conjugates can shrink tumors by hitting vessels or cells. Here the team isolates the vessel effect with a growth factor model.
A virus drives fresh vessel growth in mouse ears as a tumor stand-in. A gentler conjugate homes to those new vessels within hours. One dose breaks up growing vessels within two days. Repeated doses cause striking local tissue death with no harm to normal vessels nearby. The approach offers a fresh anti-vessel strategy for solid tumors.
Catalog record
| CREATOR | Chi-Iou Lin, Yu Liu, Tracey E. Sciuto, Anne Merley, Harold F. Dvorak, Shou-Ching S. Jaminet |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |